Skip to main content
Ambetter × Step therapy override

How to appeal your Centene / Ambetter step therapy override denial

Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. This guide is specific to Centene / Ambetter appeals.

Why Centene / Ambetter denies step therapy override

Centene operates one of the largest Medicaid footprints in the U.S. and sells ACA marketplace coverage under the Ambetter brand. Marketplace plans drew elevated regulator and journalist scrutiny in 2024 for higher-than-average denial rates on in-network claims, and Centene-managed Medicaid lines vary plan-by-plan by state.

For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.

The law that controls this appeal

Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.

What Centene / Ambetter denies for step therapy override

The step therapy override services most often denied:

  • Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
  • MS disease-modifying therapies
  • GLP-1s when a less-effective oral is preferred
  • Newer migraine therapies (CGRP inhibitors)
  • Specialty oncology when older regimens are preferred

Why step therapy override claims get denied

A typical Centene / Ambetter step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

  • Patient has not tried and failed the preferred drug
  • Documentation of prior trial / failure is incomplete
  • Plan does not recognize prior trial done under previous plan
  • Contraindication or intolerance not documented in record

The Centene / Ambetter appeal process

Appeal levels: Marketplace: internal appeal then federal external review (IRO). Medicaid: plan appeal then state fair hearing. Medicare Advantage: federal 5-level ladder.

Carrier timing: 180 days from denial for marketplace internal appeals; 4 months / 120 days for federal external review. Medicaid fair-hearing deadlines vary by state, often as short as 90-120 days.

Step therapy timing: Standard exception: typically 72 hours. Expedited urgent: 24 hours. Most state step-therapy override laws require response within 72 hours or less.

What we know about Centene / Ambetter: We confirm the specific Centene subsidiary (Ambetter, Sunshine Health, Wellcare, etc.) before filing, because procedural rules and the supervising regulator change with the line of business.

Common Centene / Ambetter denial patterns for step therapy override

  • ACA marketplace in-network denials. Ambetter marketplace plans have been documented denying in-network medical claims at rates above the marketplace average. Federal ACA rules guarantee internal appeal plus external review via an Independent Review Organization (IRO), both are no-cost to the member.
  • Narrow networks driving care-access denials. Ambetter HMO products often run narrower networks than the local competition. Network-adequacy challenges (state DOI complaints citing inadequate specialist access) can convert an out-of-network denial into in-network coverage.
  • Medicaid managed care fair hearings. Centene-managed Medicaid plans (Sunshine Health, Buckeye, Peach State, etc.) operate under each state's Medicaid rules. After plan-level appeal, members have the right to a state fair hearing, a binding administrative process with strong reversal history.

How to win your Centene / Ambetter step therapy override appeal

Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.

Filed against Centene / Ambetter, that strategy rides on this procedural spine:

  1. Procedural-rights anchor. Every Centene / Ambetter denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
  2. Criteria-disclosure demand. Centene / Ambetter frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
  3. Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
  4. Treating-provider attestation. A letter from the treating physician addressing each criterion in Centene / Ambetter's own policy language. This is the single strongest evidentiary element.
  5. Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."

Documents you'll need for your Centene / Ambetter step therapy override appeal

  • Denial letter
  • Prescription record from current and prior plans
  • Prescriber's letter documenting clinical rationale and any prior trials
  • Documentation of contraindication or intolerance (if applicable)
  • Relevant lab values or imaging supporting indication

What a step therapy override appeal can recover

Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

Centene / Ambetter step therapy override appeals: frequently asked questions

Can I get your Centene / Ambetter step therapy requirement waived?

Yes, through a step-therapy override request. Federal and many state laws require plans to grant an exception when the required first-line drug is clinically inappropriate for you.

What are the grounds for a step-therapy override?

Prior trial and failure of the preferred drug, a contraindication to it, an intolerance or adverse reaction, a clinical likelihood that it will be ineffective, or current stability on the prescribed therapy. Any one is sufficient.

How fast must Centene / Ambetter respond to an override request?

A standard exception is typically decided within 72 hours and an urgent one within 24 hours. Many state step-therapy laws codify a 72-hour-or-less response requirement.

What if my prior drug trial was under a different plan?

Bring it anyway. Pharmacy records from any prior plan can document a prior trial and failure; plans sometimes refuse to recognize outside trials, but the records are strong evidence on appeal.

What Apellica does for Centene / Ambetter step therapy override appeals

We file appeals against Centene / Ambetter specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for Centene / Ambetter appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your Centene / Ambetter step therapy override appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

Related Centene / Ambetter guides

Step therapy override guides for other carriers

Start Free Case Review